Propel Healthtech West Yorkshire is calling on innovators with healthtech solutions to apply for its accelerator programme. The programme is free for successful applicants and provides...
The FDA has approved elinzanetant, a new non-hormonal treatment for menopause that reduces hot flushes and night sweats. Clinical trials in the US, Europe and Israel...
Long-term exposure to air pollution may increase the risk of breast cancer, with a study of more than 400,000 women showing higher rates in areas with...
Women’s healthcare company Tia, backed by Melinda French Gates, has cut 72 jobs, reducing its workforce by 23 per cent across corporate and clinical divisions. Chief...
The Menopause Society has secured US$5m from the Steven & Alexandra Cohen Foundation to develop digital training for healthcare professionals. The grant will fund the digital-innovation...
Thousands of people protested in Seville on Sunday after revelations that 2,300 women were not given the results of mammogram tests showing abnormalities that required follow-up...
New funding will enable a pilot of a women’s pelvic health self-management app, aiming to cut waits and standardise support in NHS Wales. SBRI (Small Business...
Alife Health’s AI-powered embryo selection software has received CE Mark certification under the European Medical Device Regulation (MDR), allowing it to be used in fertility clinics...
Bayer has received US approval for its non-hormonal drug to relieve hot flushes linked to menopause. The US Food and Drug Administration (FDA) has approved Lynkuet...
A new testosterone patch has shown positive results in initial Phase 1 clinical testing, offering renewed hope for women seeking hormone therapy. Drug delivery firm Medherant...
